Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK208141 (Herpes Simplex Vaccine) Lot Consistency Study in Adolescent Females
NCT00224471Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2003
- Primary completion
- Sep 2005
- Modality
- Viral Vector Vaccines, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of Simplirix in herpes simplex virus infection, sponsored by GSK. Started Dec 2003; status: completed.
02
Drugs
Simplirix
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00224471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224471.